
==== Front
Sao Paulo Med J
Sao Paulo Med J
Sao Paulo Med J
São Paulo Medical Journal
1516-3180
1806-9460
Associação Paulista de Medicina - APM

11723525
10.1590/S1516-31802001000500002
Original Article
Screening for inborn errors of metabolism among newborns with metabolic disturbance and/or neurological manifestations without determined cause
de Oliveira Allan Chiaratti *
Nunes dos Santos Amélia Miyashiro *
Martins Ana Maria *
D'Almeida Vânia *
Address for correspondence: Allan Chiaratti de Oliveira Centro de Genética Médica da Universidade Federal de São Paulo/Escola Paulista de Medicina Rua Coronel Lisboa, 966 São Paulo / SP - Brasil - CEP 04020-041 E-mail: acoliveira.dped@epm.br
Conflict of interest: Not declared

01 9 2001
2001
119 5 160164
08 5 2001
05 6 2001
https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons license.
ABSTRACT

CONTEXT:

Inborn Errors of Metabolism are hereditary affections resulting from incompetence in enzymatic reactions of intermediary metabolism. At present, several hundred hereditary metabolic disturbances are known, many of which correspond to severe life-threatening disorders.

OBJECTIVE:

The early detection of carriers has motivated the screening for these disturbances among newborns at the Neonatal Unit of Hospital São Paulo, in an attempt to initiate support treatment, when available, before clinical manifestations become evident.

DESIGN:

Prospective study of risk patients.

SETTING:

Laboratory for Inborn Errors of Metabolism at the Center for Medical Genetics of the Departments of Pediatrics and Morphology of Universidade Federal de São Paulo/Escola Paulista de Medicina. Newborn care unit at a tertiary care hospital.

PARTICIPANTS:

101 children admitted into the Neonatal Unit were included in this study by presenting hypoglycemia, metabolic acidosis, jaundice, difficulty in gaining weight, diarrhea, vomiting, hepato- and/or splenomegaly, cataracts, apnea, convulsions, hypo- or hypertonia.

DIAGNOSTIC TESTS:

Tests routinely utilized, performed for qualitative research of abnormal substances excreted in the urine in situations of metabolic disorder.

RESULTS:

Children were included in the study mainly because of presenting hypoglycemia, jaundice and metabolic acidosis. Sixty-four newborns presented at least one positive test result. Most of the positivity was due to transitory metabolic alterations of the newborn, such as the case of Transitory Neonatal Tyrosinemia, presented by 29 patients. Nine infants were referred to the Center for Medical Genetics of Universidade Federal de São Paulo for continuation of the diagnostic investigation. For three of them, the tests applied permitted us to formulate a diagnostic hypothesis of mucopolysaccharidosis, tyrosinemia type I and non-ketotic hyperglycinemia, respectively.

CONCLUSIONS:

The high positivity observed in the tests reflects the newborn's own metabolic immaturity. The selection of 9% of the studied cases for outpatient follow-up confirms that Inborn Errors of Metabolism must be suspected whenever a patient presents metabolic disturbances or neurological manifestations without a determined cause. They should be researched in parallel with the other diagnostic possibilities and not just taken to be exceptional diagnoses.

RESUMO

CONTEXTO:

Os erros inatos do metabolismo são afecções hereditárias resultantes da incompetência de reações do metabolismo intermediário. Atualmente já são conhecidos centenas de distúrbios metabólicos hereditários, muitos deles correspondendo a enfermidades graves que evoluem com freqüência para o óbito, ou causam seqüelas importantes, principalmente a deficiência mental.

OBJETIVO:

A possibilidade de detecção precoce de portadores motivou a triagem desses distúrbios entre recém-nascidos da Unidade Neonatal, na tentativa de iniciar o tratamento de suporte, quando disponível, antes que as manifestações clínicas fossem evidentes.

TIPO DE ESTUDO:

Estudo prospectivo.

LOCAL:

Unidade Neonatal em Hospital Terciário.

PARTICIPANTES:

101 crianças internadas na Unidade neonatal foram incluídas no estudo por apresentarem hipoglicemia, acidose metabólica, icterícia, dificuldade de ganhar peso, diarréia, vômitos, hepato e/ou esplenomegalia, catarata, apnéia, convulsões, hipo ou hipertonia.

TESTES APLICADOS:

Testes realizados para pesquisa qualitativa de substâncias anormalmente excretadas na urina em situações de desordem metabólica.

RESULTADOS:

Os recém-nascidos foram incluídos no estudo principalmente por apresentarem hipoglicemia, icterícia e acidose metabólica. 64 recém-nascidos apresentaram pelo menos um teste com resultado positivo. A positividade foi devida principalmente a distúrbios metabólicos transitórios, como por exemplo a Tirosinemia Transitória do RecémNascido, apresentada por 29 pacientes. Nove crianças foram selecionadas e encaminhadas ao Centro Medico de Genética para continuação da investigação diagnóstica. Para três delas os testes aplicados permitiram a formulação de uma hipótese diagnóstica de mucopolissacaridose, tirosinemia tipo I e hiperglicinemia não-cetótica, respectivamente.

CONCLUSÕES:

A alta positividade observada nos testes reflete a imaturidade metabólica própria do recém-nascido. A seleção de 9% dos casos triados para acompanhamento ambulatorial confirma que os erros inatos do metabolismo devem ser suspeitados sempre que um paciente apresente distúrbios metabólicos ou manifestações neurológicas sem causa determinada, sendo pesquisados paralelamente às demais possibilidades diagnósticas e não apenas tidos como diagnósticos de exceção.

KEY WORDS:

Inborn Errors of Metabolism
Inherited Metabolic Disorders
Newborns
Urinary Screening
PALAVRAS-CHAVE:

Erros inatos do metabolismo
Distúrbios metabólicos hereditários
Recém-nascidos
Triagem urinária
==== Body
pmcINTRODUCTION

Inborn Errors of Metabolism are hereditary affections resulting from incompetence in enzymatic reactions of intermediary metabolism, due both to deficiency in the enzyme involved and to its lower activity or stability. This blockage generally causes an increase in the precursor for the compromised metabolic stage and a lack of subsequent intermediaries or activation of alternative metabolic routes, leading to the production of substances normally not encountered in the organism. These errors may occur in the metabolism of all the organic compounds, both in synthesis and catabolism situations and in energy production, with a great number of diseases resulting from these metabolic disturbances.1 At present, several hundred hereditary metabolic disturbances are known, many of which correspond to grave illnesses that frequently evolve to death or cause important sequelae, especially mental deficiency.2

Considered individually, inborn errors of metabolism present very variable incidences. Considered as a whole, they present a cumulative frequency of 1:500 newborns5 and are readily encountered in medical practice.3–5 In spite of this fact, the clinical diversity that these diseases present makes it difficult to recognize them clinically, with specific diagnosis being extremely dependent on laboratory assistance.6,7

The organized study and systematized planning of the diagnostic conditions among possible inborn errors of metabolism carriers would appear to be very promising activities insofar as these may make it possible to prevent and control morbidity that not long ago was considered to be irremediable.8 Moreover, such studies open the way towards therapy, which could be very efficacious in some cases, with continual advances being incorporated,9 as well as making it viable to offer genetic counseling and assistance in the couple's reproductive prognosis.7,10 Within inborn errors of metabolism diagnosis programs, biochemical screening procedures are of fundamental importance, as these serve as a first indication of the general metabolic routes that the alterations can be involved in, and the more specific tests needed for proceeding with the evaluation.11,12

Thus, the possibility of early detection of carriers has motivated the screening for these disturbances among newborns at the Neonatal Unit of the Hospital São Paulo, in an attempt to initiate support treatment, when available, before clinical manifestations become evident.

METHODS

This study was made at the Laboratory for inborn errors of metabolism at the Center for Medical Genetics of the Departments of Pediatrics and Morphology of the Universidade Federal de São Paulo/Escola Paulista de Medicina (UNIFESP/EPM). The sample for this study was made up by neonates born in the Hospital São Paulo during a 14-month period.

Children were included in this study if they fulfilled the following inclusion criteria: presence of clinical or asymptomatic hypoglycemia (glycemia less than 40 mg/dl), metabolic acidosis (fall of 0.15 in pH and fall of 10 mEq/l in bicarbonate), jaundice, difficulty in gaining weight (weight gain <10g over four consecutive days, despite a calorific offer > 100 cal/kg), diarrhea, vomiting, hepato- and/or splenomegaly, cataracts, apnea, convulsions, hypo- or hypertonia.

The neonatal population was classified according to the sex, gestational age, chronological age, and appropriateness of weight to gestational age. The gestational age was calculated using Naegele's rule13 and by Dubowitz's method,14 performed between 6 and 24 hours after birth. The gestational age determined by Dubowitz's method14 was considered when the difference between this and the gestational age calculated using Naegele's rule13 was greater than two weeks, or when the date of the last maternal menstruation was not known, or further, when the maternal information was imprecise.

To classify the gestational age, the World Health Organization criteria15 were used, and the newborns were considered to be full-term when their gestational age ranged between 37 completed weeks and 42 uncompleted weeks, pre-term when the gestational age was less than 37 weeks, and post-term when the gestational age was greater than or equal to 42 weeks.

To classify the newborns according to gestational age and birth weight, the Battaglia & Lubchenko16 intra-uterine growth curves were utilized. Newborns were considered to have appropriate weight for the gestational age when the weight was located between the 10th and 90th percentiles of this curve. They were considered to be large for the gestational age when the birth weight was above the 90th percentile, and small for the gestational age when the weight was below the 10th percentile.

The newborns included in the study were submitted to the tests routinely utilized in the Laboratory for Inborn Errors of Metabolism at the Center for Medical Genetics, based on qualitative research for abnormal substances excreted in the urine in situations of metabolic disorder, as described by Buist,17 Giogio & Luhby18 and Thomas,19 and aminoacid urine chromatography 20.

The results from the tests were analyzed in parallel with the clinical information available, and in accordance with the demographic data for the newborns obtained from consulting their medical records from the internment in the Neonatal Unit.

All tests with a positive result were repeated, using a new urine sample, as a form of follow-up for these newborns. In the same way, all the newborns that persisted with the clinical alterations cited in the inclusion criteria for the study, but presented normal results in the first tests performed, had their tests repeated.

RESULTS

The sample studied was made up of 101 newborns selected from among the births occurring at the Neonatal Unit during a 14 month period, representing 6.8% of the total number of births during the period (n = 1477).

These newborns were predominantly male, premature and with weight appropriate to the gestational age (Table 1). They were included in the study mainly because of the development of hypoglycemia, jaundice or metabolic acidosis (Table 2) and the majority were submitted to screening tests in the first week of life (61.4%).

Table 1 Baseline characteristics of participants

Characteristics	n (%)	
Sex	
Male	60 (59.4%)	
Female	41 (40.6%)	
Gestational Age	
Pre-term	64 (63.3%)	
Term	34 (33.7%)	
Post-term	3 (3%)	
Birth Weight	
Small	23 (22.8%)	
Appropriate	72 (71.3%)	
Large	6 (5.9%)	
Clinical Signs (Number of events#)	
Hypoglycemia	62 (61.4%)	
Jaundice	56 (55.4%)	
Metabolic acidosis	51 (50.5%)	
Respiratory disturbance	44 (43.6%)	
Apnea	14 (5.3%)	
Seizures	12 (13.9%)	
Hepatomegaly	6 (5.9%)	
Hypotonia	6 (5.9%)	
Ocular alterations	5 (4.9%)	
Coma	3 (2.9%)	
Difficulty in gaining weight	3 (2.9%)	
Vomiting	3 (2.9%)	
Lethargy	1 (0.9%)	
# Some patients presented more than one sign.

Table 2 Positive results for each applied test and situations for which they are usualyusually positive

Positive situation	Tests	Positive results	
Tyrosinemia	Nitrosonaphthol	30 (29.7%)	
Mucopolysaccharidosis	CTA Bromide	20 (19.8%)	
Mucopolysaccharidosis	Toluidine Blue	1 (1.0%)	
Amino aciduria	Chromatographic alterations	19 (18.8%)	
Reducing substances, particularly sugar, as in galactosemia, fructosemia	Benedict	9 (8.9%)	
Organic aciduria	2,4-dinitrophenyl-hydrazine	2 (2.0%)	
Cystinuria-Homocystinuria	Cyanide-nitroprusside	1 (1.0%)	
Methylmalonic aciduria	p-nitroaniline	-	
Phenylketonuria, tyrosinemia, maple syrup urine disease, histidinemia, alkaptonuria	Ferric Chloride	-	

Of these newborns, 63.4% presented at least one positive test result. The individual results of the tests are shown in Table 3, along with the conditions for them to be positive.17,18,21

Table 3 Influence of gestational age and post-natal age on test positivity, expressed as number of newborns with positive tests

Gestational age	Post-natal age	
1 to 7 days	8 to 14 days	> 14 days	Total	
Pre-term	26 (40.6%)	14 (21.9%)	5 (7.8%)	45 (70.3%)	
Full and post-Term	13 (20.3%)	3 (4.7%)	3 (4.7%)	19 (29.7%)	
Total	39 (60.9%)	17 (26.6%)	8 (12.5%)	64 (100.0%)	
c 2= 0.63; (g.l. = 4); P = 0.89.

Table 3 shows the characteristics of the newborns that may be related to the presentation of a positive result in the tests applied, compared using the chi-squared (c2) test.

The majority of the positive results were observed in premature patients (c2 = 3.55) and in those submitted to tests in the first week of life (c2 = 2.56), even though these differences were not statistically significant. The association of both conditions in the newborns with positive results was not significant (c2 = 0.63) (Table 3).

For three of the patients studied, the tests applied permitted us to formulate a diagnostic hypothesis with greater confidence, respectively of mucopolysaccharidosis, tyrosinemia type I and non-ketotic hyperglycinemia, as will be seen in the discussion, although these tests alone did not confirm the diagnosis.

Regarding two other infants referred onwards, the diagnostic hypotheses were made mainly from the clinical findings. and the family history. One of them, included in the study because of presenting convulsive crises and hepatosplenomegaly, whose screening tests that were all normal, had two deceased sisters whose clinical state had included convulsions, loss of learned skills and hepatic insufficiency, for whom a diagnostic hypothesis of Alpers’ Syndrome had been proposed. The second child mentioned, the daughter of consanguineous parents, presented cyanosis, vomiting, tremor (without presenting hypoglycemia), convulsions, apnea, bradycardia, hypotonia and microcephaly. This child also had screening tests with normal results and had a family history of two deceased brothers with the same clinical condition. For this child, a diagnostic hypothesis of pyruvate dehydrogenase complex deficiency was put forward.

The other four children referred all presented persistent metabolic acidosis, two of whom also presented convulsive crises. For one of these, a low protein diet was introduced during its internment in the Neonatal Unit, which reversed the metabolic acidosis condition. In none of these four patients did the screening tests permit the establishment of a diagnostic hypothesis.

DISCUSSION

Among the 101 newborns studied, approximately 63% presented a positive result in at least one of the tests to which they were submitted. Of all the tests applied, three merit highlighting because of the large numbers of positive results.

The cetyltrimethyl-ammonium bromide test, utilized for the detection of glycosaminoglycans in the urine, was a test that presented a great number of false-positive results. It was positive in situations in which the newborn also presented a positive result for other substances not normally encountered in urine, such as reducing substances, or an altered pattern of amino acid excretion in the urine. For this reason, this test was utilized as an indicator for performing the toluidine blue test, a more specific test for the detection of glycosaminoglycans in the urine. With this latter test, only one positive result was found and in this case, there was an indication for the follow-up of the patient for investigation of mucopolysaccharidosis.

In addition to the cetyltrimethyl-ammonium bromide test, the nitrosonaphthol test (specific for the detection of tyrosine and an excess of its metabolites in urine) also presented large positivity (29.7%), which we did not, however, consider to be a false-positive result. We believe that these are related to the newborn's own metabolic immaturity, especially when compared to the positivity of this test in examinations performed routinely at the Laboratory for Inborn Errors of Metabolism at the Center for Medical Genetics, which is only 1.0% (N = 1000).

These positive tests would indicate cases of transitory neonatal tyrosinemia. This condition is believed to be the most common alteration in the metabolism of amino acids in human beings, with an incidence of 10% having been described among full-term newborns and between 30 and 50% among premature newborns.22 This condition does not have an exclusive genetic determination (late maturation of hydroxyphenylpyruvate dehydrogenase and tyrosine amino transferase),26 but is also related to prematurity, high protein ingestion during the first days of life (> 3 g of protein/kg weight), low birth weight, low ingestion of vitamin C (a cofactor in compromised metabolic routes), among other factors.22–26

Transitory Neonatal Tyrosinemia is considered to be a benign condition, although there is a lack of recent studies to confirm this information.27 In older studies, a reduction in motor activity of these newborns was observed in relation to normal controls paired by gestational and post-natal ages,28 lethargy,25 and an intellectual deficit in children assessed around the ages of 4 to 5 years,29 although another study did not show any neurological or developmental alteration in children with transitory neonatal tyrosinemia assessed at 2 years of age. Nevertheless, greater morbidity was observed among these children, especially related to the respiratory system.30

Recently, Jardim et al.31 evaluated children presenting transitory neonatal tyrosinemia at 4 years of age, observing slight intellectual deficits in these children in comparison with the control group. In this same study, a possible association of this condition with behavioral problems such as attention deficit and hyperactivity was suggested.

In our sample, the newborns that presented this condition were predominantly premature (80.0%), born with weight appropriate to the gestational age (70.0%), submitted to screening tests within the first two weeks of life (93.3%) and presented metabolic acidosis (73.3%), respiratory insufficiency (60.0%), hypoglycemia (56.7%), jaundice (53.3%) and sepsis (46.7%) during hospital internment.

When they presented a positive result in the nitrosonaphthol test, the newborns received oral supplements of vitamin C (100 mg/day)22 and had their test repeated after approximately one week, so that the transitoriness of the disturbance could be confirmed. Only one result continued to be positive after the repetition of the test, and the patient was referred to the Genetic Unit with a diagnostic hypothesis of tyrosinemia type I.

Regarding the alterations on aminoacid urine chromatograms, the majority of them were transitory alterations, except for one patient who continued with increased excretion in the glycine migration band, which is being followed up with a diagnostic hypothesis of non-ketotic hyperglycinemia.

As in the case of hypertyrosinemia, these transitory alterations are a result of the newborn's own immaturity, which is known to be capable of causing alterations in the excretion of various aminoacids.32 They have the same contributory factors, i.e. prematurity, low weight, the quantity and quality of the diet, the rate of growth and renal immaturity.33,34

Although we selected 9% of the patients for outpatient follow-up, these patients are still proceeding with investigations to confirm the diagnosis. Our percentage of selected individuals for further investigation is greater than that found in other studies made on selected populations in Brazil, which have shown inborn errors of metabolism detection rates of between 6.5 and 7.7%.35–38 On the other hand, a more recent work from Sanseverino et al.11 detected a 13% rate of inborn errors of metabolism in patients from pediatric and neonatal intensive care units with more similarities to the group of patients we studied.

CONCLUSION

The high positivity observed in the screening tests is of fundamental importance for directing the clinical investigation, especially in places where more specific examinations are unavailable. It depends on an intimate association between the interpretation of the biochemical tests and a specialized multi-disciplinary clinical investigation.

The selection of 9% of the screened cases for outpatient follow-up confirms that inborn errors of metabolism must be suspected whenever a patient presents metabolic disturbances or neurological manifestations without a determined cause. They should be researched in parallel with the other diagnostic possibilities and not just taken to be exceptional diagnoses.

Allan Chiaratti de Oliveira. Postgraduate Medical Student, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Amélia Miyashiro Nunes dos Santos, MD, MSc. Discipline of Neonatal Pediatrics, Department of Pediatrics, Federal Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Ana Maria Martins, MD, PhD. Center for Medical Genetics, Discipline of General Pediatrics, Department of Pediatrics, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Vânia D'Almeida, PhD. Center for Medical Genetics, Discipline of General Pediatrics, Department of Pediatrics, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil.

Sources of funding: Allan Chiaratti de Oliveira holds a fellowship from PIBIC/CNPq.

Center for Medical Genetics, Departments of Pediatrics and Morphology, Universidade Federal de São Paulo/Escola Paulista de Medicina, São Paulo, Brazil
==== Refs
REFERENCES

1 Beaudet AL Scriver CR Sly WS Valle D Genetics, biochemistry and molecular bases of variant human phenotypes Beaudet AL Scriver CR Sly WS Valle W The metabolic bases of inherited Deseasedisease on CD-ROM 7th edition New York McGraw-Hill Book Company 1995
2 Goodman SI Inherited metabolic disease in the newborn: approach to diagnosis and treatment Adv Pediatr 1986 33 197 224 3541531
3 Zschocke J Hoffmann GF Vademecum metabolicum: manual of metabolic pediatrics Milupa 1st ed. Stuttgart Schttauer 1999
4 Hoffmann GF Selective screening for inborn errors of metabolism: past, present and future Eur J Pediatr 1994 153 Suppl 1 S2 S8
5 Duran M Dorland L Wadman SK Berger R Group tests for selective screening of inborn errors of metabolism Eur J Pediatr 1994 153 Suppl 1 S27 S32
6 Shih VE Introduction and summary of clinical findings in inborn errors of metabolism Shih VE Laboratory techniques for the detection of hereditary metabolic disorders 1st Edition Boca Raton, Flórida CRC Press 1973 1 10
7 Synnes AR Use of the laboratory in prediction of outcome in the high-risk newborn Clinical Chemistry 1997 43 1 243 248 8990260
8 Anonymous Serving the family from birth to the medical home. A report from the Newborn Screening Task Force convened in Wasshington DC, May 10-11, 1999 Pediatrics 2000 106 2 Pt 2 383 427 10947680
9 Treacy E Childs B Scriver CR Response to Treatement in hereditary metabolic disease: 1993 survey and 10-year comparison Am J Hum Genet 1995 56 359 367 7847368
10 Green ED Cox DR Myers RM The Human Genome Project and its impact on the study of human disease Beaudet AL Scriver CR Sly WS Valle W The metabolic bases of inherited disease on CD-ROM 7th edition New York McGraw-Hill Book Company 1995
11 Sanseverino MTV Wajner M Giugliani R Aplicação de um protocolo clínico-laboratorial de erros inatos do metabolismo em crianças gravemente enfermas Jornal de Pediatria 2000 76 5 375 382 14647647
12 Blau N Blaskovics ME Duran M Simple tests in urine and blood Blau N Blaskovics ME Duran M Physician's guide to the laboratory diagnosis of metabolic diseases 1st Edition London Chapman & Hall Medical 1996 3 11
13 Delascio D Guarniento A Diagnóstico em obstetricia São Paulo Sarvier 1981 271 281
14 Dubowitz LMS Dubowitz V Goldberg C Clinical assessment of gestational age in the newborn infant J Pediatr 1970 77 1 10 5430794
15 World Health Organization Recomended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths Acta Obstet Gynecol Scand 1977 56 247 253 560099
16 Battaglia FC Lubchenko LO A practical classification of newborn infants by weight and gestational age J Pediatr 1967 71 159 163 6029463
17 Buist N Set of simple side-room urine tests for detection of inborn errors of metabolism British Med J 1968 2 745 749
18 Giorgio AJ Luhbi LL A rapid screening test for the detection of congenital methylmalonic aciduria in infancy Am J Clin Path 1968 39 8 374 379
19 Thomas GH Howell RR Selected screening tests for genetic metabolic diseases Chicago Yearbook Medical Publishers 1973 36 36
20 Efron ML Young D Moser HW MacCready RA A simple chromatographic screening test for the detection of disorders of amino acid metabolism: a technique using whole blood or urine collected on filter paper N Engl J Med 1964 270 1378 1383 14152868
21 Shih VE Mandel R Sheinhait I General metabolic screening tests Hommes FA Techniques in diagnostic human biochemical genetics: a laboratory manual Wiley-Liss 1991 46 68
22 Mitchell GA Lambert M Tanguay RM Hypertyrosinemia Beaudet AL Scriver CR Sly WS Valle W The metabolic bases of inherited disease on CD-ROM 7th edition New York McGraw-Hill Book Company 1995
23 Komrower GM Robins AJ Plasma amino acid disturbance in infancy I: hypermethioninemia and transient tyrosinemia Arch Dis Child 1969 44 418 421 5785193
24 Morris AF Holton JB Burman D Colley JRT Phenylalanine and tyrosine levels in newborn screening blood samples Arch Dis Childh 1983 58 271 275 6847230
25 Driscoll DJ Jabs EW Alcorn D Maumenee IH Brusilow SW Valle D Corneal tyrosine crystals in transient neonatal tyrosinemia Clin Lab Obs 1988 113 1 91 93
26 Blau N Beck M Matern D Tetrahydrobiopterin induced neonatal tyrosinemia Eur J Pediatr 1996 155 9 832 832 8874126
27 Jardim LB Tirosinemia neonatal transitória: doença ou variação do normal? Jornal de Pediatria 1998 74 6 431 432 14685583
28 Partington MW Campbell D Kuyek J Mehlomakulu M Motor activity in early life: premature babies with neonatal tyrosinemia; a pilot study Biol Neonate 1971 18 1 121 128 5123899
29 Mamunes P Prince PE Thornton NH Hunt PA Hitchcock ES Intellectual deficits after transient tyrosinemia in the term neonate Pediatrics 1976 57 675 680 940707
30 Partington MW Delayaye DJ Masotti RE Read JR Roberts B Neonatal Tirosinemiatyrosinemia: a follow-up study Arch Dis Childh 1968 43 195 199 5645691
31 Jardim LB Hauck S Forcelini C Weber E Knijnik M Giugliani R Transient tyrosinemia of newborn: intellectual deficits revisited II Congreso Latinoamericano de Errores Innatos del Metabolismo y Pesquisa Neonatal 1999 92 93
32 Nutrition Committee, Canadian Pediatric Society Nutrition needs and feeding of premature infants Can Med Assoc J 1995 152 11 1756 1785
33 Scott PH Berger HM Wharton BA Growth velocity and plasma amino acid in the newborn Pediatr Res 1985 19 446 450 4000770
34 Wharton BA Scott PW Distinctive aspects of metabolism and nutrition in infancy Clinical Biochemistry 1996 29 5 419 428 8884062
35 Wajner M Wannamacher CMD Gaidzinsk D Detection of inborn errors of metabolism in patients of pediatric intensive care units of Porto Alegre, Brazil: comparison of the prevalence of such disturbances in a selected and an unselected sample Rev Brasil Genet 1986 IX 2 331 340
36 Coelho JC Wajner M Burin MG Vargas CR Giugliani R Selective screening of 10,000 high-risk Brazilian patients for the detection of inborn errors of metabolism Eur J Pediatr 1997 156 650 654 9266201
37 Pereira MB Conceição GC Coelho JC Wajner M Giugliani R Detection of metabolic disorders in high-risk patients Arq Neuropsiquiatr 1997 55 2 209 212 9629379
38 Simoni RL Oliveira CPH Grassiano DM Screening for inborn errors of metabolism in high-risk children from Rio de Janeiro, Brazil Early Hum Dev 1998 50 305 311 9548034
